Kidney Injury Molecule Levels in Type 2 Diabetes Mellitus

This study was designed to determine the diagnostic role of urinary kidney injury molecule (KIM)‐1 levels in renal damage in patients with type 2 diabetes mellitus according to the urinary albumin/creatinine ratio.

[1]  J. Delanghe,et al.  Urinary kidney injury molecule-1 and neutrophil gelatinase-associated lipocalin as indicators of tubular damage in normoalbuminuric patients with type 2 diabetes. , 2016, Clinical biochemistry.

[2]  N. Wareham,et al.  Epidemiology of diabetes , 2014, Medicine.

[3]  S. Bakker,et al.  Glomerular and Tubular Damage Markers Are Elevated in Patients With Diabetes , 2011, Diabetes Care.

[4]  J. Bonventre,et al.  Regression of microalbuminuria in type 1 diabetes is associated with lower levels of urinary tubular injury biomarkers, kidney injury molecule-1, and N-acetyl-β-D-glucosaminidase. , 2011, Kidney international.

[5]  D. Choudhury,et al.  Diabetic nephropathy -- a multifaceted target of new therapies. , 2010, Discovery medicine.

[6]  P. Devarajan.  The use of targeted biomarkers for chronic kidney disease. , 2010, Advances in chronic kidney disease.

[7]  H. Parving,et al.  Neutrophil Gelatinase‐Associated Lipocalin (NGAL) and Kidney Injury Molecule 1 (KIM1) in patients with diabetic nephropathy: a cross‐sectional study and the effects of lisinopril , 2010, Diabetic medicine : a journal of the British Diabetic Association.

[8]  P. Maxwell.  Managing diabetic nephropathy. , 2010, The Practitioner.

[9]  Y. Bao,et al.  Urinary Pigment Epithelium-Derived Factor as a Marker of Diabetic Nephropathy , 2010, American Journal of Nephrology.

[10]  P. Nawroth,et al.  Urinary L‐FABP and anaemia: distinct roles of urinary markers in type 2 diabetes , 2010, European journal of clinical investigation.

[11]  R. Atkins,et al.  Diabetic kidney disease: act now or pay later , 2010, Nephron Clinical Practice.

[12]  S. Bakker,et al.  Kidney injury molecule‐1 in renal disease , 2010, The Journal of pathology.

[13]  J. Bonventre.  Kidney injury molecule-1 (KIM-1): a urinary biomarker and much more. , 2009, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[14]  S. Satchell,et al.  What is the mechanism of microalbuminuria in diabetes: a role for the glomerular endothelium? , 2008, Diabetologia.

[15]  J. Bonventre.  Kidney Injury Molecule‐1 (KIM‐1): A specific and sensitive biomarker of kidney injury , 2008, Scandinavian journal of clinical and laboratory investigation. Supplementum.

[16]  M. C. V. D. Heuvel,et al.  Tubular kidney injury molecule‐1 (KIM‐1) in human renal disease , 2007, The Journal of pathology.

[17]  G. Bakris,et al.  Microalbuminuria and chronic kidney disease as risk factors for cardiovascular disease. , 2006, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[18]  V. Fonseca,et al.  Diabetic nephropathy and retinopathy. , 2004, The Medical clinics of North America.

[19]  R. T. Hurst,et al.  Increased Incidence of Coronary Atherosclerosis in Type 2 Diabetes Mellitus: Mechanisms and Management , 2003, Annals of Internal Medicine.

[20]  P. Zimmet.  The burden of type 2 diabetes: are we doing enough? , 2003, Diabetes & Metabolism.

[21]  J. Bonventre,et al.  Kidney Injury Molecule-1 (KIM-1): a novel biomarker for human renal proximal tubule injury. , 2002, Kidney international.

[22]  J A ROBERTSON,et al.  Renal function in diabetic nephropathy. , 1951, A.M.A. archives of internal medicine.

[23]  Bancha Satirapoj,et al.  Nephropathy in Diabetes , 2023, Experimental and Clinical Endocrinology & Diabetes.

[24]  S. Satchell,et al.  Diabetic nephropathy. , 2012, Clinical medicine.

[25]  Mark E Molitch,et al.  Nephropathy in diabetes. , 2004, Diabetes care.

[26]  J. Kastrup,et al.  Microalbuminuria: an early marker of renal involvement in diabetes. , 1985, Uremia investigation.